Intensity Therapeutics, Inc. (INTS)
NASDAQ: INTS · Real-Time Price · USD
0.3741
-0.0004 (-0.11%)
At close: Feb 11, 2026, 4:00 PM EST
0.3800
+0.0059 (1.58%)
After-hours: Feb 11, 2026, 7:59 PM EST
Intensity Therapeutics Market Cap
Intensity Therapeutics has a market cap or net worth of $22.47 million as of February 11, 2026. Its market cap has decreased by -35.88% in one year.
Market Cap
22.47M
Enterprise Value
15.52M
1-Year Change
-35.88%
Ranking
Category
Stock Price
$0.37
Market Cap Chart
Since the IPO on June 30, 2023, Intensity Therapeutics's market cap has decreased from $66.01M to $22.47M, a decrease of -65.96%. That is a compound annual growth rate of -33.73%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 10, 2026 | 22.49M | -8.70% |
| Dec 31, 2025 | 24.64M | -7.32% |
| Dec 31, 2024 | 26.58M | -77.37% |
| Dec 29, 2023 | 117.49M | 77.98% |
| Jun 30, 2023 | 66.01M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Daré Bioscience | 24.15M |
| IGC Pharma | 23.99M |
| Vistagen Therapeutics | 22.24M |
| Neuphoria Therapeutics | 21.67M |
| Jupiter Neurosciences | 20.64M |
| Anebulo Pharmaceuticals | 20.56M |
| Polyrizon | 20.47M |
| IN8bio | 19.43M |